171 related articles for article (PubMed ID: 11489496)
1. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
[TBL] [Abstract][Full Text] [Related]
2. Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates.
Kasuya Y; Lu ZR; Kopecková P; Tabibi SE; Kopecek J
Pharm Res; 2002 Feb; 19(2):115-23. PubMed ID: 11883637
[TBL] [Abstract][Full Text] [Related]
3. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
Kunath K; Kopecková P; Minko T; Kopecek J
Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
Tijerina M; Kopecková P; Kopecek J
Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
[TBL] [Abstract][Full Text] [Related]
6. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
Omelyanenko V; Kopecková P; Gentry C; Kopecek J
J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
[TBL] [Abstract][Full Text] [Related]
7. Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells.
Nishiyama N; Nori A; Malugin A; Kasuya Y; Kopecková P; Kopecek J
Cancer Res; 2003 Nov; 63(22):7876-82. PubMed ID: 14633716
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
[TBL] [Abstract][Full Text] [Related]
9. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
[TBL] [Abstract][Full Text] [Related]
10. FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.
Yang J; Zhang R; Radford DC; Kopeček J
J Control Release; 2015 Nov; 218():36-44. PubMed ID: 26410808
[TBL] [Abstract][Full Text] [Related]
11. Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
Lu ZR; Kopecková P; Kopecek J
Nat Biotechnol; 1999 Nov; 17(11):1101-4. PubMed ID: 10545917
[TBL] [Abstract][Full Text] [Related]
12. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
Minko T; Kopecková P; Pozharov V; Kopecek J
J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
14. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
15. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers.
Wang D; Kopecková JP; Minko T; Nanayakkara V; Kopecek J
Biomacromolecules; 2000; 1(3):313-9. PubMed ID: 11710118
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.
Borgman MP; Aras O; Geyser-Stoops S; Sausville EA; Ghandehari H
Mol Pharm; 2009; 6(6):1836-47. PubMed ID: 19743884
[TBL] [Abstract][Full Text] [Related]
18. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
19. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
[TBL] [Abstract][Full Text] [Related]
20. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
